JP2023523414A5 - - Google Patents
Info
- Publication number
- JP2023523414A5 JP2023523414A5 JP2022563870A JP2022563870A JP2023523414A5 JP 2023523414 A5 JP2023523414 A5 JP 2023523414A5 JP 2022563870 A JP2022563870 A JP 2022563870A JP 2022563870 A JP2022563870 A JP 2022563870A JP 2023523414 A5 JP2023523414 A5 JP 2023523414A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- nucleic acid
- self
- acid sequence
- virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063013456P | 2020-04-21 | 2020-04-21 | |
| US63/013,456 | 2020-04-21 | ||
| US202063020473P | 2020-05-05 | 2020-05-05 | |
| US63/020,473 | 2020-05-05 | ||
| PCT/US2021/028486 WO2021216776A2 (en) | 2020-04-21 | 2021-04-21 | Capping compounds, compositions and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023523414A JP2023523414A (ja) | 2023-06-05 |
| JP2023523414A5 true JP2023523414A5 (https=) | 2024-05-01 |
Family
ID=78269927
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022563870A Pending JP2023523414A (ja) | 2020-04-21 | 2021-04-21 | キャッピング化合物、組成物、及びその使用方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230303614A1 (https=) |
| EP (1) | EP4138854A4 (https=) |
| JP (1) | JP2023523414A (https=) |
| KR (1) | KR20230015914A (https=) |
| CN (1) | CN115768437A (https=) |
| AU (1) | AU2021260932A1 (https=) |
| CA (1) | CA3173803A1 (https=) |
| IL (1) | IL296855A (https=) |
| WO (1) | WO2021216776A2 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3198727A1 (en) * | 2020-10-20 | 2022-04-28 | St Pharm Co., Ltd. | Oligonucleotide for 5'-capped rna synthesis |
| CN113603739B (zh) * | 2021-08-27 | 2024-08-23 | 上海兆维科技发展有限公司 | 一种加帽类似物及其应用 |
| AU2022380858A1 (en) * | 2021-11-08 | 2024-05-30 | Seattle Project Corp. | Self-amplifying rna compositions and methods of use thereof |
| US20250108066A1 (en) * | 2022-01-27 | 2025-04-03 | Trilink Biotechnologies, Llc | Trinucleotide cap analogs and methods of use thereof |
| CN115260264B (zh) * | 2022-02-28 | 2023-06-09 | 广州市恒诺康医药科技有限公司 | 用于rna加帽的化合物及其应用 |
| EP4261217A4 (en) | 2022-02-28 | 2024-09-11 | Guangzhou Henovcom Bioscience Co., Ltd. | Compound for rna capping and application of compound |
| CN119563028A (zh) * | 2022-05-12 | 2025-03-04 | 尚威天成信使核糖核酸治疗公司 | 具有分泌抗原和免疫调节物的合成自扩增mRNA分子 |
| WO2024075022A2 (en) * | 2022-10-04 | 2024-04-11 | BioNTech SE | Rna constructs and uses thereof |
| WO2025037891A1 (ko) * | 2023-08-14 | 2025-02-20 | 에스티팜 주식회사 | 5'-캡핑된 rna 합성용 올리고뉴클레오티드 |
| CN120082547B (zh) * | 2025-05-06 | 2025-10-03 | 北京悦康科创医药科技股份有限公司 | 用于自复制mRNA的加帽类似物及其应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992003568A1 (en) * | 1990-08-13 | 1992-03-05 | Isis Pharmaceuticals, Inc. | Sugar modified oligonucleotides that detect and modulate gene expression |
| CN120842296A (zh) * | 2015-09-21 | 2025-10-28 | 垂林克生物技术有限公司 | 用于合成5’-加帽rna的组合物和方法 |
| BE1024796B9 (fr) | 2016-06-02 | 2019-01-08 | Glaxosmithkline Biologicals Sa | Constructions antigeniques du virus zika |
| US10487105B2 (en) * | 2016-10-19 | 2019-11-26 | Arcturus Therapeutics, Inc. | Trinucleotide MRNA cap analogs |
| JP2020500552A (ja) * | 2016-11-23 | 2020-01-16 | グリットストーン オンコロジー インコーポレイテッド | 新生抗原のウイルスによる送達方法 |
| EP3634449A4 (en) * | 2017-05-08 | 2021-03-17 | Gritstone Oncology, Inc. | ALPHAVIRUS NEOANTIGEN VECTORS |
| WO2019036682A1 (en) * | 2017-08-18 | 2019-02-21 | Modernatx, Inc. | RNA VARIANTS POLYMERASE |
-
2021
- 2021-04-21 CA CA3173803A patent/CA3173803A1/en active Pending
- 2021-04-21 AU AU2021260932A patent/AU2021260932A1/en active Pending
- 2021-04-21 JP JP2022563870A patent/JP2023523414A/ja active Pending
- 2021-04-21 CN CN202180044091.7A patent/CN115768437A/zh active Pending
- 2021-04-21 KR KR1020227040442A patent/KR20230015914A/ko active Pending
- 2021-04-21 EP EP21792935.5A patent/EP4138854A4/en active Pending
- 2021-04-21 IL IL296855A patent/IL296855A/en unknown
- 2021-04-21 WO PCT/US2021/028486 patent/WO2021216776A2/en not_active Ceased
-
2022
- 2022-10-20 US US18/048,407 patent/US20230303614A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023523414A5 (https=) | ||
| JP2021525076A5 (https=) | ||
| JP2022512912A5 (https=) | ||
| JP2023526495A5 (https=) | ||
| EP3813874A1 (en) | Novel lassa virus rna molecules and compositions for vaccination | |
| JP2023541108A5 (https=) | ||
| JP2022534282A5 (https=) | ||
| CN115768437A (zh) | 加帽化合物、组合物及其使用方法 | |
| JP2022539417A5 (https=) | ||
| JP2021524247A5 (https=) | ||
| JP2023523413A5 (https=) | ||
| CN118556131A (zh) | 用于蛋白质表达的mRNA及其模板 | |
| JPWO2012053646A1 (ja) | ワクシニアウイルスベクターおよびセンダイウイルスベクターからなるプライム／ブーストワクチン用ウイルスベクター | |
| CN106459997A (zh) | 用于疫苗应用的高效价病毒样囊泡的进化 | |
| JP2023521662A5 (https=) | ||
| JP2004501646A5 (https=) | ||
| CA3236106A1 (en) | Modified arenavirus particles expressing mutant kras, mutated cancer driver gene, or tumor-associated antigen as cancer immunotherapies | |
| TW202245809A (zh) | 用於治療b型肝炎病毒感染之組合療法 | |
| JP2022536945A (ja) | Ｂ型肝炎ウイルス（ＨＢＶ）ワクチンおよびＨＢＶを標的化するＲＮＡｉの組合せ | |
| JP2024542126A5 (https=) | ||
| Li et al. | mRNA vaccines: current applications and future directions | |
| JP2021507707A5 (https=) | ||
| CN120888569A (zh) | 一种自复制mRNA疫苗及其制备方法和用途 | |
| KR20240099240A (ko) | 자가 증폭 rna 조성물 및 이의 사용 방법 | |
| JP2024546964A5 (https=) |